• |
  • |
  • |
  • |
Donate

Project

A Phase 3 Study of MEDI-254 (NUMAX)

Center:
Fiscal Year:
2013
Contact Information:
Project Description:
A Phase 3 Study of MEDI-254 (NUMAX), An Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prevention of RSV Disease Among Navajo and White Mountain Apache Infants
Keyword(s):
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals
Unserved or Under-served Populations:
Geographic Areas, Reservation
Primary Target Audience Geographic Descriptor:
State
Funding Source:
COVID-19 Related Data:
N/A